Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Jebasingh

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Diabetes Research and Clinical Practice|September 19, 2019
Efficacy and safety of evogliptin versus sitagliptin as an add-on therapy in Indian patients with type 2 diabetes mellitus inadequately controlled with metformin: A 24-week randomized, double-blind, non-inferiority, EVOLUTION INDIA studyAjay Kumar Ajmani, Aparna Agrawal, B L N Prasad, et al.
The Lancet. Global Health|February 16, 2023
The Global Alliance for Chronic Diseases researchers' statement on non-communicable disease research with Indigenous peoplesDavid P Meharg, Violet Naanyu, Boe Rambaldini, et al.
The Lancet. Global Health|January 10, 2026
Recognising type 5 diabetes - Authors' replyMeredith Hawkins, Peter Schwarz, Chittaranjan S Yajnik, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Diabetes Research and Clinical Practice|September 19, 2019
Efficacy and safety of evogliptin versus sitagliptin as an add-on therapy in Indian patients with type 2 diabetes mellitus inadequately controlled with metformin: A 24-week randomized, double-blind, non-inferiority, EVOLUTION INDIA studyAjay Kumar Ajmani, Aparna Agrawal, B L N Prasad, et al.
The Lancet. Global Health|February 16, 2023
The Global Alliance for Chronic Diseases researchers' statement on non-communicable disease research with Indigenous peoplesDavid P Meharg, Violet Naanyu, Boe Rambaldini, et al.
The Lancet. Global Health|January 10, 2026
Recognising type 5 diabetes - Authors' replyMeredith Hawkins, Peter Schwarz, Chittaranjan S Yajnik, et al.
Pageof 5